Chimerix Inc - Company Profile

Powered by

All the data and insights you need on Chimerix Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Chimerix Inc Strategy Report

  • Understand Chimerix Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Chimerix Inc (Chimerix) is a biopharmaceutical company. It develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s pipeline product portfolio includes ONC201, ONC206, ONC212, CMX521 drug candidates. Its products are used to treat various diseases like gliomas, central nervous system tumors, COVID-19 and IND-enabling studies. Its brincidofovir tablet and oral suspension formulations are used in the treatment of smallpox disease in adult and pediatric patients. The company markets its products under the brand name TEMBEXA. The organization works in partnership with Oncoceutics, Inc., Cantex Pharmaceuticals, BARDA, and SymBio Pharmaceuticals. Chimerix is headquartered in Durham, North Carolina, the US.

Gain a 360-degree view of Chimerix Inc and make more informed decisions for your business Gain a 360-degree view of Chimerix Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 2505 Meridian Parkway, Suite 100, Durham, North Carolina, 27713


Telephone 1 919 8061074

No of Employees 72

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CMRX (NASD)

Revenue (2022) $324,000 -99% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -147.7% (2022 vs 2021)

Market Cap* $79.5M

Net Profit Margin (2022) XYZ -5,077.9% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Chimerix Inc premium industry data and analytics

60+

Clinical Trials

Determine Chimerix Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Catalyst Calendar

Proactively evaluate Chimerix Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Chimerix Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

14+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

5

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Chimerix Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Chimerix Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Pipeline TEMBEXA
ONC201 (To Treat Gliomas)
ONC206 (To Treat Central Nervous System Tumors)
XYZ
XYZ
XYZ
Understand Chimerix Inc portfolio and identify potential areas for collaboration Understand Chimerix Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Chimerix Inc Aclaris Therapeutics Inc Scorpius Holdings Inc DMK Pharmaceuticals Corp Abeona Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Durham Wayne Morrisville San Diego Cleveland
State/Province North Carolina Pennsylvania North Carolina California Ohio
No. of Employees 72 91 77 11 84
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Mike Sherman Chairman Executive Board 2023 -
Mike Andriole Chief Executive Officer; President Senior Management 2023 -
Michelle LaSpaluto Chief Financial Officer Senior Management 2023 -
Roy W. Ware Chief Technology Officer; Chief Manufacturing Officer Senior Management 2017 -
Joshua E. Allen Chief Technology Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Chimerix Inc key executives to enhance your sales strategy Gain insight into Chimerix Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code